SCHEMBL6444775

SCHEMBL6444775

O=CC1=CCC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10997116 0.77
SCHEMBL11052535 0.77
SCHEMBL826097 0.76
Valine SCHEMBL9065812 0.76 SLC7A5 (0.46)
SCHEMBL6443901 0.74
SCHEMBL13726484 0.74
SCHEMBL19743656 0.72 ALDH1A1 (0.33)
SCHEMBL19743658 0.72 ALDH1A1 (0.33)
SCHEMBL19743657 0.72 ALDH1A1 (0.33)
SCHEMBL1225045 0.69 HCAR2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3952114-A 1,4-Cyclohexadiene-1-carboxaldehyde syn-oxime synthetic sweetening agents STANFORD RESEARCH INSTITUTE (US) 1976-04-20 US claimed
US-20250319047-A1 ANTIMICROBIAL TREATMENT AND PREVENTION BY PERILLYL ALCOHOL AND DERIVATIVES ZAYAS RIVERA JOSE (US) 2025-10-16 US disclosed
CN-111989317-B Polymerizable liquid crystal compound, polymerizable liquid crystal composition, polymer, optical film, optically anisotropic body, and polarizing plate 日本瑞翁株式会社 2023-12-01 CN disclosed
CN-111989317-A Polymerizable liquid crystal compound, polymerizable liquid crystal composition, polymer, optical film, optically anisotropic body, polarizing plate, display device, and antireflection film 日本瑞翁株式会社 2020-11-24 CN disclosed
US-20050130941-A1 Methods of treating alzheimer's disease PHARMACIA & UPJOHN COMPANY LLC 2005-06-16 US disclosed
US-6436961-B1 SUBSTANCE P RECEPTOR ANTAGONIST; 2-PHENYL-3-BENZYLAMINOPIPERIDINES PFIZER INC 2002-08-20 US disclosed
US-6071895-A RETROVIRAL PROTEASES INHIBITOR; USEFUL FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS VIRAL INFECTIONS SUCH AS ACQUIRED IMMUNODEFICIENCY SYNDROME(AIDS); COMPOUND CONTAINING A CYCLIC DIAZAALKANE GROUP NARHEX LIMITED (HK) 2000-06-06 US disclosed
US-6008228-A COMPRISING A MIXTURE OF CARRIER MONOGLYCERIDES OF MEDIUM CHAIN-FATTY ACIDS HOFFMAN-LA ROCHE INC. (US) 1999-12-28 US disclosed
US-5888992-A PROTEASE INHIBITOR; VIRICIDE NARHEX LIMITED (HK) 1999-03-30 US disclosed
US-5753652-A Antiretroviral hydrazine derivatives NOVARTIS CORPORATION (US) 1998-05-19 US disclosed
EP-0233841-A1 Quinone derivatives and process for their preparation Arai, Tadashi, Prof. (JP) 1987-08-26 EP disclosed
US-4613676-A PEPTIDES CIBA-GEIGY CORPORATION (US) 1986-09-23 US disclosed
EP-0184550-A2 5-Amino-4-hydroxy valeryl amide derivatives CIBA-GEIGY AG (CH) 1986-06-11 EP disclosed
EP-0143746-A2 5-Amino 4-hydroxy-valeryl-substituted derivatives CIBA-GEIGY AG (CH) 1985-06-05 EP disclosed
EP-0056615-B1 PROCESS FOR THE PREPARATION OF CARNITINAMIDE LONZA AG (CH) 1984-06-13 EP disclosed
US-3952114-A 1,4-Cyclohexadiene-1-carboxaldehyde syn-oxime synthetic sweetening agents STANFORD RESEARCH INSTITUTE (US) 1976-04-20 US disclosed
US-3952114-A 1,4-Cyclohexadiene-1-carboxaldehyde syn-oxime synthetic sweetening agents STANFORD RESEARCH INSTITUTE (US) 1976-04-20 US disclosed
US-3952114-A 1,4-Cyclohexadiene-1-carboxaldehyde syn-oxime synthetic sweetening agents STANFORD RESEARCH INSTITUTE (US) 1976-04-20 US disclosed
US-3919318-A 1,4-Cyclohexadiene-1-carboxaldehyde syn-oxime synthetic sweetening agents STANFORD RESEARCH INST 1975-11-11 US disclosed
US-3919318-A 1,4-Cyclohexadiene-1-carboxaldehyde syn-oxime synthetic sweetening agents STANFORD RESEARCH INST 1975-11-11 US disclosed